Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Self-Image in Women with Parkinson's Disease.

  • Authors : Mathur S; PD Avengers (Global Alliance to End Parkinson's Disease), Vancouver, BC, Canada.; LaMonica K

Subjects: Menopause* ; Parkinson Disease*; Female

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2023; Vol. 13 (3), pp. 329-332.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Neurodegenerative Diseases*; Humans

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2023; Vol. 13 (4), pp. 427-439.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Waiting for PARIS-A Biological Target in Search of a Drug.

Subjects: Dopaminergic Neurons* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy; Humans

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (1), pp. 95-103.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update.

Subjects: Drug Development* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy; COVID-19

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (4), pp. 1073-1082.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

The Parkinson's Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson's Disease in Patients and their Carers.

  • Authors : Tolosa E; Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Ebersbach G

Subjects: Caregivers*/Caregivers*/Caregivers*/statistics & numerical data ; Cost of Illness* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2021; Vol. 11 (3), pp. 1309-1323.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update.

Subjects: Antiparkinson Agents*/Antiparkinson Agents*/Antiparkinson Agents*/therapeutic use ; Drug Development*; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*statistics & numerical data

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2021; Vol. 11 (3), pp. 891-903.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.

  • Authors : Barker RA; Cambridge Centre for Brain Repair, Department of Clinical Neuroscience and WT-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Björklund A

Subjects: Glial Cell Line-Derived Neurotrophic Factor/Glial Cell Line-Derived Neurotrophic Factor/Glial Cell Line-Derived Neurotrophic Factor/*metabolism ; Neuroprotective Agents/Neuroprotective Agents/Neuroprotective Agents/*therapeutic use ; Parkinson Disease/Parkinson Disease/Parkinson Disease/*therapy

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (3), pp. 875-891.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020.

Subjects: Drug Development*; Antiparkinson Agents/Antiparkinson Agents/Antiparkinson Agents/*therapeutic use ; Neuroprotective Agents/Neuroprotective Agents/Neuroprotective Agents/*therapeutic use

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (3), pp. 757-774.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity.

  • Authors : Mursaleen L; School of Life Sciences, University of Westminster, London, UK.; Department of Pharmaceutics, UCL School of Pharmacy, London, UK.

Subjects: Nanotechnology*; Antioxidants/Antioxidants/Antioxidants/*administration & dosage ; Curcumin/Curcumin/Curcumin/*administration & dosage

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (1), pp. 99-111.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×
Academic Journal

Parkinson Matters.

  • Authors : Darweesh SKL; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.; Parkinson Center Nijmegen, Radboud University Medical Center, Nijmegen, The Netherlands.

Subjects: Parkinson Disease/Parkinson Disease/Parkinson Disease/*epidemiology ; Parkinsonian Disorders/Parkinsonian Disorders/Parkinsonian Disorders/*epidemiology; Cause of Death

  • Source: Journal of Parkinson's disease [J Parkinsons Dis] 2018; Vol. 8 (4), pp. 495-498.Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101567362 Publication Model: Print Cited Medium:

تفاصيل العنوان

×